ConductScience.org, home

Comparison · NCT03338400-77dc52f6

Normal Saline vs Dexamethasone: Readmissions

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Normal Saline vs Dexamethasone: Readmissions. Trial comparisons, record NCT03338400-77dc52f6. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03338400-77dc52f6

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1670.06680.359wilson
Risk in group 20.04550.008070.218wilson
Risk difference, group 1 minus group 20.121-0.07810.317newcombe hybrid score
Risk ratio, group 1 over group 23.670.44330.4log
Odds ratio, group 1 over group 24.20.43240.9log
Number needed to treat, for one more participant with the outcome on Normal Saline than on Dexamethasone8.25from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Normal SalineER visits post-op424OG000
Group 2DexamethasoneER visits post-op122OG001

Outcome

Type
SECONDARY
Title
Readmissions
Description
Any patient that is re-admitted to the hospital and the reason for re-admission will be collected.
Time frame
6 weeks
Population
Number or ER visits post-op

Source ClinicalTrials.gov

Trial

Title
Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?
NCT number
NCT03338400
Phases
PHASE2
Conditions
Quality of Recovery, Same Day Surgery, Nausea and Vomiting, Postoperative, Vaginal Prolapse
Interventions
Dexamethasone, Normal saline
Lead sponsor
The Cleveland Clinic
Results first posted
2019-05-10

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03338400-77dc52f6